Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Achillion Pharmaceuticals

(NASDAQ: ACHN)
Add to Portfolio
-0.01 (-0.16%)
as of 13:01 EST

Last 6.23
Change -0.01 (-0.16%)
Open 6.25
Prev. Close 6.24
Today's Range
6.22
6.25
52wk Range
2.06
6.46
Volume 2,150,899
Avg Volume 2,225,436
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
ACHN -0.16% -1.97% +171.09%
DJIA +0.09% +6.73% +20.40%
S&P 500 +0.20% +8.13% +26.13%

Key Statistics

Annual EPS -0.54
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 861,290
Weighted Alpha +15.08
Standard Deviation -0.10
Profit Margin -1,517.55%
Beta 1.59

Growth Rates

YTD +3.40%
1-Year +184.93%
3-Year +53.69%
5-Year -60.98%
10-Year +164.41%

Opinion

Sell Hold Buy

Recent Headlines

Achillion Shareholders Approve Agreement to be

GlobeNewswire via COMTEX - Thu Dec 19, 09:24AM EST
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced that its shareholder(full story)
ALXN: 113.96 (+1.45), ACHN: 6.23 (-0.01)

Achillion Reports Positive Data from Phase 2 Study of

GlobeNewswire via COMTEX - Mon Dec 09, 10:00AM EST
- 2.4 g/dL mean increase in hemoglobin at 24 weeks -(full story)
ACHN: 6.23 (-0.01)

Rigrodsky & Long, P.A. Files Class Action Suit Against

GlobeNewswire via COMTEX - Fri Nov 29, 11:30PM EST
Rigrodsky & Long, P.A.:(full story)
ACHN: 6.23 (-0.01), ALXN: 113.96 (+1.45)

Moore Kuehn, PLLC Encourages Investors of SRC Energy,

PR Newswire via COMTEX - Fri Nov 22, 10:42AM EST
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations(full story)
SRCI: 4.00 (-0.09), ACHN: 6.23 (-0.01), ARTX: 2.99 (unch)

European Medicines Agency Grants PRIME Designation to

GlobeNewswire via COMTEX - Tue Nov 19, 07:30AM EST
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced that the European Me(full story)
ACHN: 6.23 (-0.01)